Project archive

Cancel
  • Microscopic image of cardiac muscle cells stained green and blue.

    Researchers participating in the RNA Therapeutics platform by the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD are studying circRNAs in human cardiomyocytes from patients that have experienced a SARS-CoV-2 infection.

    more info
  • EU project TBMED

    Open-innovation test bed for high-risk medical devices

    As part of the EU-project TB Med, Fraunhofer ITEM and 12 other project partners are actively participating in the development of a test bed for medical devices of risk classifications IIb and III.

    more info
  • Working with cell cultures.

    To enable better assessment of the safety also of future drugs, Fraunhofer ITEM researchers are developing innovative model systems for assessing immunomodulatory therapeutics.

    more info
  • Nico Lachmann holding a reaction vessel.

    Biomedical researchers are exploring alternative ways of obtaining such immune cells of human origin. Prof. Lachmann and his team have developed a new method laying a foundation for producing them in consistent quality and on large scale.

    more info
  • Fraunhofer ITEM researchers use the ex-vivo model of the isolated perfused rat lung (IPL). In this alternative model, they studied the transition of a fluorescence-labeled substance into the perfusate, which served as blood substitute in this model. Two different methods were used to generate aerosols with different droplet sizes.

    more info
  • The web application Genealyzer abstracts away mathematical and programmatical details in order to enable a convenient and customizable analysis of microarray data for large-scale reproducibility studies.

    more info